Prelude Therapeutics Incorporated

NASDAQ:PRLD

Biotechnology

Healthcare
$3.32 -3.22%

-$0.14 today

Market cap
$192.16M
Beta
1.01
P/E (TTM)
-4.5
EPS (TTM)
-$0.94
52W Low $0.75High $5.54

Volume 0.42M

Average 0.38M

Private 5-step workspace

Build a PRLD investment thesis

Turn Prelude Therapeutics Incorporated research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.